CrushSCI.com
89.8Average days
82Median days
19Fastest days
232Longest days
3032025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

30 days

Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?

Authors
Luca Rapparini; Ginevra Martelli; Stephano Cedirian; Francesca Pampaloni; Francesca Bruni; Michela StaraceShow moreShow less
Affiliations
1. Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 2. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, ItalyShow moreShow less
Source PDF DOI Publisher page
38 days

Age-Associated Differences in Facial Skin Structure in Chinese Women: a Cross-Sectional Study

Authors
Chengfeng Zhang; Keming Wang; Lin Gao; Jiewei Wu; Vladimir Melnikov; Yucong Wang; Hequn Wang; Weimin Song; Hang Wang; Zongke Guo; Xiaoqin Wang; Frederic Flament; Bin Yang; Qin Li; Fei Liu; Leihong XiangShow moreShow less
Affiliations
1. Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China; 2. Department of Plastic and Reconstructive Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 3. Department of Dermatology and Medical Aesthetics, Xi’an Honghui Hospital, Xi’an, China; 4. L’Oreal Dermatological Beauty China, SkinCeuticals, Shanghai, China; 5. Research and Innovation Center, L’Oreal China, Shanghai, China; 6. Research and Innovation Center, L’Oreal U.S., Clark, USA; 7. YesSkin Clinic, Hangzhou, China; 8. Department of Dermatology, Cosmetic Center, West China Hospital of Stomatology, Sichuan University, Chengdu, China; 9. Department of Plastic and Aesthetic Surgery, The Second Hospital of Nanjing University of Chinese Medicine, Nanjing, China; 10. Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China; 11. Research and Innovation Center, L’Oreal S.A., Clichy, France; 12. Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, China; 13. Department of Plastic and Aesthetic Surgery, AIST Medical Aesthetic Group, Guangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
90 days

Describing Patient Characteristics, Treatment Patterns, and Disease Burden Among Patients with Alopecia Areata in Mexico: A Secondary Analysis of the Adelphi Real World Alopecia Areata Disease Specific Programme

Authors
Luis E. Sanchez-Duenas; Ashley S. Cha-Silva; Peter Anderson; Martha Alicia Aceves-Villalvazo; Veronica J. Guajardo-Barron; Carlos A. Barrera-Ochoa; Raul A. Becerra-Cerecedo; Jorge Alberto Barragan Garfias; William Jones; Samantha K. Kurosky; Nelly A. Espinoza-GonzalezShow moreShow less
Affiliations
1. Department of Dermatology, Instituto Dermatologico de Jalisco, “Dr. Jose Barba Rubio”, University of Guadalajara, Guadalajara, Mexico; 2. Pfizer Inc, New York, USA; 3. Adelphi Real World, Bollington, UK; 4. Dr. Valentin Gomez Farias Regional Hospital, Guadalajara, Mexico; 5. Pfizer Mexico, Mexico City, Mexico; 6. Dermatology Department, Hospital General Dr. Manuel Gea Gonzalez, Mexico City, Mexico; 7. Clinical Science Department, School of Medicine, University of Monterrey, Dermatology Center of Monterrey, Monterrey, MexicoShow moreShow less
Source PDF DOI Publisher page
199 days

Malar Edema after Hyaluronic Acid Dermal Fillers: Expert Recommendations on Etiology, Prevention, and Management

Authors
Wioletta Baranska‑Rybak; José V. Lajo‑Plaza; Lee Walker; Navid AlizadehShow moreShow less
Affiliations
1. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdańsk, Poland; 2. Centro Médico Lajo-Plaza, Madrid, Spain; 3. BCity Clinics, Liverpool, UK; 4. Care Geneva Aesthetics, Geneva, SwitzerlandShow moreShow less
Source PDF DOI Publisher page
49 days

Oral Retinol, Alone or Combined with Medical Photoprotection, in Patients with Actinic Keratosis: A Randomized, Open-Label, Prospective, Multicentric Study

Authors
Marco Ardigò; Martina Burlando; Elena Campione; Gianluca Nazzaro; Giulio Foggi; Francesca Colombo; Stefano Alfano; Massimo Milani; Angelo V. MarzanoShow moreShow less
Affiliations
1. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; 2. Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy; 3. Dermatology Unit, IRCCS San Martino University Hospital, Genoa, Italy; 4. Dermatological Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 5. Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 6. Department of Pathophysiology and Transplantation, Università Degli Studi Di Milano, Milan, Italy; 7. Medical Department, Cantabria Labs Difa Cooper, Caronno Pertusella, ItalyShow moreShow less
Source PDF DOI Publisher page
82 days

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”

Authors
Saroja Rao; Isabella Midura; Kathyana P. Santiago Mangual; Leon I. Igel; Katherine H. Saunders; Jocelyn Carter; Jenny E. Murase; Arianne Shadi KouroshShow moreShow less
Affiliations
1. Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, USA; 2. Wake Forest University School of Medicine, Winston-Salem, USA; 3. Department of Medicine, Yale School of Medicine, New Haven, USA; 4. Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, Comprehensive Weight Control Center, New York, USA; 5. FlyteHealth, New Canaan, USA; 6. Division of General Internal Medicine, Massachusetts General Hospital, Boston, USA; 7. Department of Dermatology, University of California, San Francisco, San Francisco, USA; 8. Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, USA; 9. Harvard Medical School, Boston, USA; 10. Harvard T.H. Chan School of Public Health, Boston, USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.